about
Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.Effects of Recombinant Circularly Permuted Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) (Recombinant Mutant Human TRAIL) in Combination with 5-Fluorouracil in Human Colorectal Cancer Cell Lines HCT116 and SW480.
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
TRAIL-NP hybrids for cancer therapy: a review.
@en
TRAIL-NP hybrids for cancer therapy: a review.
@nl
type
label
TRAIL-NP hybrids for cancer therapy: a review.
@en
TRAIL-NP hybrids for cancer therapy: a review.
@nl
prefLabel
TRAIL-NP hybrids for cancer therapy: a review.
@en
TRAIL-NP hybrids for cancer therapy: a review.
@nl
P2093
P2860
P50
P356
P1433
P1476
TRAIL-NP hybrids for cancer therapy: a review
@en
P2093
P2860
P304
P356
10.1039/C7NR01469D
P407
P577
2017-05-01T00:00:00Z